Evidence map›Paper›PMID 27681430›Full record

ArticleCell reports2016

MERVL/Zscan4 Network Activation Results in Transient Genome-wide DNA Demethylation of mESCs.

Mélanie A Eckersley-Maslin, Valentine Svensson, Christel Krueger, Thomas M Stubbs, Pascal Giehr, Felix Krueger, Ricardo J Miragaia, Charalampos Kyriakopoulos, Rebecca V Berrens, Inês Milagre and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 227 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Mélanie A Eckersley-MaslinEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK. Electronic address: eckersleym@babraham.ac.uk.
Valentine SvenssonEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Christel KruegerEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Thomas M StubbsEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Pascal GiehrLaboratory of EpiGenetics, Saarland University, Campus A2 4, 66123 Saarbrücken, Germany.
Felix KruegerBioinformatics Group, Babraham Institute, Cambridge CB22 3AQ, UK.
Ricardo J MiragaiaEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK; Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Charalampos KyriakopoulosComputer Science Department, Saarland University, Campus E1.3, 66123 Saarbrücken, Germany.
Rebecca V BerrensEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Inês MilagreEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK.
Jörn WalterLaboratory of EpiGenetics, Saarland University, Campus A2 4, 66123 Saarbrücken, Germany.
Sarah A TeichmannEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Wolf ReikEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, UK; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK. Electronic address: wolf.reik@babraham.ac.uk.
Babraham Institute · GBEuropean Bioinformatics Institute · GBSaarland University · DEWellcome Sanger Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K010867/1Wellcome Trust 095645/Z/11/Z
6 · The paper itself

Abstract

Mouse embryonic stem cells are dynamic and heterogeneous. For example, rare cells cycle through a state characterized by decondensed chromatin and expression of transcripts, including the Zscan4 cluster and MERVL endogenous retrovirus, which are usually restricted to preimplantation embryos. Here, we further characterize the dynamics and consequences of this transient cell state. Single-cell transcriptomics identified the earliest upregulated transcripts as cells enter the MERVL/Zscan4 state. The MERVL/Zscan4 transcriptional network was also upregulated during induced pluripotent stem cell reprogramming. Genome-wide DNA methylation and chromatin analyses revealed global DNA hypomethylation accompanying increased chromatin accessibility. This transient DNA demethylation was driven by a loss of DNA methyltransferase proteins in the cells and occurred genome-wide. While methylation levels were restored once cells exit this state, genomic imprints remained hypomethylated, demonstrating a potential global and enduring influence of endogenous retroviral activation on the epigenome.

Indexed as

Epigenesis, GeneticGenomeTranscriptomeAnimalsCell CycleCellular ReprogrammingChromatinDNA MethylationDNA Modification MethylasesEndogenous RetrovirusesGenomic ImprintingInduced Pluripotent Stem CellsMiceMouse Embryonic Stem CellsMultigene FamilyRNA, MessengerChromatinDNA Modification MethylasesRNA, MessengerTranscription FactorsZscan4c protein, mousechromatinDNA methylationembryonic stem cellendogenous retrovirusimprintMERVLpreimplantationreprogrammingZscan4

Identifiers

PMID27681430
PMCPMC5055476
OpenAlexW2526632574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.